Abstract
There is scant controlled data to guide the use of repeat kidney biopsies to guide therapy in glomerular disease. De Rosa et al. assessed the value of a repeat biopsy during remission in estimating the risk of subsequent relapse of lupus nephritis. They demonstrated the feasibility of a per-protocol repeat biopsy study with prespecified subsequent therapy. Their results will inform the design of future studies of repeat biopsies in lupus nephritis and other kidney diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 659-661 |
Number of pages | 3 |
Journal | Kidney international |
Volume | 94 |
Issue number | 4 |
DOIs |
|
State | Published - Oct 2018 |
Bibliographical note
Publisher Copyright:© 2018 International Society of Nephrology